␤-Adrenergic stimulation of the heart results in bisphosphorylation of the N-terminal extension of cardiac troponin I (TnI). Bisphosphorylation of TnI reduces the affinity of the regulatory site on troponin C (TnC) for Ca 2؉ by increasing the rate of Ca 2؉ dissociation. What remains unclear is how the phosphorylation signal is transmitted from one subunit of troponin to another. We have produced a series of mutations in the N-terminal extension of TnI designed to further our understanding of the mechanisms involved. The ability of phosphorylation of the mutant TnIs to affect Ca 2؉ sensitivity has been assessed. We find that the Pro residues found in a conserved (Xaa-Pro) 4 motif N-terminal to the phosphorylation sites are not required for the effect of the Nterminal extension on Ca 2؉ binding in the presence or absence of phosphorylation. Our experiments also reveal that the full effects of phosphorylation are seen even when residues 1-15 of TnI are deleted. If further residues are removed, not only does the effect of phosphorylation diminish but deletion of the N-terminal extension mimics phosphorylation. We propose that TnI residues 16 -29 bind to TnC stabilizing the "open" Ca 2؉bound state. Phosphorylation (or deletion) prevents this binding, accelerating Ca 2؉ release.
␤-Adrenergic stimulation of the heart results in bisphosphorylation of the N-terminal extension of cardiac troponin I (TnI). Bisphosphorylation of TnI reduces the affinity of the regulatory site on troponin C (TnC) for Ca 2؉ by increasing the rate of Ca 2؉ dissociation. What remains unclear is how the phosphorylation signal is transmitted from one subunit of troponin to another. We have produced a series of mutations in the N-terminal extension of TnI designed to further our understanding of the mechanisms involved. The ability of phosphorylation of the mutant TnIs to affect Ca 2؉ sensitivity has been assessed. We find that the Pro residues found in a conserved (Xaa-Pro) 4 motif N-terminal to the phosphorylation sites are not required for the effect of the Nterminal extension on Ca 2؉ binding in the presence or absence of phosphorylation. Our experiments also reveal that the full effects of phosphorylation are seen even when residues 1-15 of TnI are deleted. If further residues are removed, not only does the effect of phosphorylation diminish but deletion of the N-terminal extension mimics phosphorylation. We propose that TnI residues 16 -29 bind to TnC stabilizing the "open" Ca 2؉bound state. Phosphorylation (or deletion) prevents this binding, accelerating Ca 2؉ release.
Troponin, working in conjunction with tropomyosin, acts as a molecular switch, regulating muscle contraction in response to changes in the intracellular Ca 2ϩ concentration. Troponin is a complex of three proteins: the Ca 2ϩ binding subunit, troponin C (TnC), 1 the inhibitory subunit, troponin I (TnI), and the tropomyosin binding subunit, troponin T (TnT). Crystal and NMR structures (1, 2) reveal that TnC is a dumbbell-shaped molecule, consisting of a C-terminal domain possessing two Ca 2ϩ / Mg 2ϩ binding sites (sites III and IV) and a N-terminal domain possessing two Ca 2ϩ -specific binding sites (sites I and II) in the skeletal isoform. The binding of Ca 2ϩ at sites I and II produces a structural opening of the N-terminal domain exposing additional TnI binding sites (1, 3) . In cardiac TnC site I is inactive (4) , and it is Ca 2ϩ binding to site II that is the primary regulator of cardiac contractility. Binding of Ca 2ϩ to the single "regulatory" site of cardiac TnC alone is not sufficient to stabilize the open conformation of the N-terminal domain in the absence of TnI (2) . However, in the presence of TnI and Ca 2ϩ the N-terminal domain of cardiac TnC also adopts the open conformation (5) .
Although we do not yet have atomic resolution structures of TnI and TnT, much information has been afforded by studies with fragments and mutants of these proteins. TnI is an extended molecule that adopts an antiparallel orientation to TnC in the binary complex (6, 7) . Cardiac TnI (209 amino acids) has a 31-residue extension not present in other isoforms. Fig. 1 shows the aligned sequences of the N-terminal extensions of the mammalian cardiac TnIs sequenced to date (8 -12) . Within this extension are two residues, serines 22 and 23, which are substrates for cAMP-dependent protein kinase (PKA). C-terminal to the extension, residues 33-80 of cardiac TnI form an ␣-helix that binds extremely tightly to the C-terminal domain of TnC (13, 14) . 2 This is followed by a putative TnT binding site and then the "inhibitory" (115-131) and "regulatory" (147-163) regions (5, 15) . These latter regions bind to Ca 2ϩ -saturated TnC but, in the absence of Ca 2ϩ , bind to actin-anchoring troponin and tropomyosin in the "blocked state" of the McKillop and Geeves (16) model of thin filament regulation.
Serines 22 and 23 of cardiac TnI are phosphorylated by PKA in response to ␤-adrenergic stimulation of the heart. This bisphosphorylation desensitizes the thin filaments to Ca 2ϩ by 0.2-0.4 pCa units (17) (18) (19) due to an increase in the rate of Ca 2ϩ dissociation from the N-terminal regulatory site on TnC (19) . The faster release of Ca 2ϩ produces faster relaxation of skinned fibers upon rapid Ca 2ϩ chelation (20) . This enhanced relaxation, in conjunction with increased Ca 2ϩ re-uptake into the sarcoplasmic reticulum, may help maintain proper diastolic function at increased heart rates.
Despite intensive efforts, it remains unclear how the phosphorylation signal is transmitted from the N-terminal extension of TnI to the regulatory Ca 2ϩ binding site in the Nterminal domain of TnC, especially in view of the antiparallel orientation of the two proteins. 1 H NMR experiments on peptides corresponding to regions of the N-terminal extension show that the unphosphorylated extension is highly flexible but that bisphosphorylation increases the number of conformational restraints with residues 24 -29 adopting a looped conformation (21, 22) . 1 H and 31 P NMR on these peptides or whole TnI indicates that phosphoserine 23 interacts with Arg 21 , whereas phosphoserine 22 behaves as if free in solution (22, 23) . In bisphosphorylated troponin the phosphate groups are in a more acidic environment than in isolated TnI, which suggests that the phosphorylated extension may interact weakly with another component of troponin. However, the narrow 31 P line widths observed were interpreted to indicate that the phosphate groups themselves are not involved in specific bond formation (23) . Isolated TnI and the TnI⅐TnC complex both adopt a more compact shape upon phosphorylation (24) and fluorescence resonance energy transfer experiments have shown that the extreme N-terminal region of a S5C mutant TnI labeled with 2-(4Ј-(iodoacetamido)anilino)napthalene-6-sulfonic acid (IAANS) moves 10 -12 Å toward the rest of TnI (25) . Binding experiments using peptides corresponding to the N-terminal extension have shown that the unphosphorylated form will bind to TnC, whereas the phosphorylated form does not (21, 26, 27) . The peptide work is supported by NMR and cross-linking data, which indicate that the unphosphorylated N-terminal extension contacts the N-terminal domain of TnC in both TnI⅐TnC binary complex and in whole troponin (28 -31) . Bisphosphorylation results in a change in the net charge on the N-terminal extension from ϩ2 to Ϫ2, and it is likely that this significantly alters the properties of the extension. Replacement of serines 22 and 23 with negatively charged Asp residues mimics the effects of phosphorylation in skinned fibers (17) but does not produce the same conformational change in a TnI peptide (residues 19 -29) as phosphorylation (21) .
It seems likely that the phosphorylation signal is transmitted from TnI to TnC by alterations in a direct interaction between the N-terminal extension and the N-terminal domain of TnC. We now investigate the minimal structural requirements of the N-terminal extension required for successful transmission of the phosphorylation signal. It has been shown that (Xaa-Pro) n sequences favor an extended rigid conformation of the polypeptide chain (32, 33) . We initially set out to test whether the (Xaa-Pro) 4 sequence found in the N-terminal extension acts as a rigid spacer arm (residues 10 -17) conducting localized phosphorylation-induced conformational changes toward the N terminus of TnI. This might alter any proteinprotein interactions formed by the extreme N terminus (residues 1-9) of TnI. Our results indicate that this is not the case, because Pro 3 Ala mutations in this region do not alter the ability of bisphosphorylation to produce two of its characteristic effects: desensitization of actomyosin ATPase activity toward Ca 2ϩ and acceleration of Ca 2ϩ release from troponin labeled at Cys 35 of TnC with IAANS. We have also progressively deleted residues from the N terminus of TnI leading to three major conclusions: 1) residues 1-15 do not play a major role in transmitting the phosphorylation signal to TnC, 2) residues 16 -18 are required for the full effect, and 3) deletion of residues 16 -29 mimics phosphorylation. The implications of these findings are discussed later.
EXPERIMENTAL PROCEDURES
Materials-Recombinant human cardiac TnC, TnI, TnT, and ␣-tropomyosin were used in this study and purified as previously described (34, 35) . pET11c(TnC) and pET11c(TnI) constructs were provided by Dr. E. Al-Hillawi, and pET11c(TnT) and pET11c(TM) constructs were provided by E. Austin and B. Wright, respectively. Skeletal TnT, actin, and myosin were purified as described previously (36, 37) . All protein concentrations were determined using the bicinchoninic acid protein assay (Pierce) calibrated with bovine serum albumin. Oligonucleotide primers were produced by Alta Bioscience (University of Birmingham) and DNA-sequenced at the Functional Genomics facility (University of Birmingham, Biotechnology and Biological Sciences and Research Council 6/JIF13209). Bovine PKA (catalytic subunit) was obtained from Sigma. IAANS was from Molecular Probes. [␥-33 P]ATP was from PerkinElmer Life Sciences. Platinum Pfx DNA polymerase was from Invitrogen. All other DNA-modifying enzymes were from New England BioLabs, and Escherichia coli strains were from Novagen.
Mutagenesis, Expression, and Purification-Oligonucleotide-directed mutagenesis by PCR using 5Ј-primers with an NdeI site and 3Ј-primers with a BamHI site was as described previously (38) . Briefly, base pair substitutions were achieved by mega-primer synthesis by PCR using Platinum Pfx DNA polymerase, followed by a second PCR to extend the DNA to the whole coding region. The N-terminal deletions of TnI were prepared via a single PCR reaction. Following BamHI/NdeI digestion, the PCR products were ligated into pET11c and transformed into competent E. coli JM101 cells. Successful clones were screened for by restriction analysis and DNA sequencing. Proteins were overexpressed in E. coli Rosetta cells and purified by ion exchange chromatography in "urea buffer" (8 M urea, 25 mM triethanolamine/HCl (pH 7.5), 1 mm EDTA, 1 mM dithiothreitol) as previously described (38) . Protein purity (Ͼ95%) and identity were analyzed by SDS-PAGE and electrospray mass spectrometry (34) .
Actomyosin ATPase Measurements-The troponin was prepared by mixing TnC, TnI, and TnT in a 1:1:1 ratio in urea buffer followed by extensive dialysis against "ATPase buffer" (25 mM KCl, 20 mM MOPS/ KOH (pH 7.0), 1 mM dithiothreitol). PKA was also dialyzed against ATPase buffer. Assay conditions were: 4 M actin, 1 M tropomyosin, 1 M troponin, 0.1 M myosin, 3 mM MgCl 2 , 2.5 mM ATP, 1 mM EGTA, and CaCl 2 to give the required pCa. Prior to addition of the myosin to the reactions, the reaction mix was incubated at 30°C for 15 min with or without 50 units of PKA/ml. In all experiments the paired Ϯ PKA reaction mixes were prepared and assayed in parallel. Following addition of myosin, ATP hydrolysis was calculated from the P i released during a 15-min incubation at 30°C. The P i assay was adapted to 96-well plate format from Bilmen et al. (39) : the 50-l ATPase reactions were stopped by the addition of 150 l of chilled 0.2 M sodium acetate (pH 4.0), 0.25% (w/v) copper sulfate. This was followed by 25 l of 5% (w/v) ammonium molybdate and 25 l of 5% (w/v) sodium sulfite, 2% (w/v) p-methylaminophenol sulfate. The absorbance at 850 nm was determined after 10 min at room temperature. Control experiments showed that the absorbance was linearly proportional to the P i concentration, that P i release was linear during our ATPase experiments, and that the percentage of ATP hydrolyzed did not exceed 25%.
Ca 2ϩ Release Measurements-A C84S mutant TnC was labeled at Cys-35 with IAANS by dissolving in 6 M urea, 25 mM triethanolamine/ HCl (pH 7.5), 1 mM EDTA and incubating at 4°C overnight with a 5-fold molar excess of IAANS. Unincorporated IAANS was removed by dialysis. The IAANS-labeled TnC was then incorporated into troponin by mixing with TnI and TnT in a 1:1:1 ratio in urea buffer. The complex was extensively dialyzed against "stopped-flow buffer" (100 mM KCl, 20 mM MOPS/KOH (pH 7.0), 3 mM MgCl 2 , 50 M CaCl 2 ) and then diluted to 5 M and 1 mM ATP added. PKA was also dialyzed against stopped-flow buffer. The troponin was incubated for 1 h at 25°C with or without 50 units PKA/ml. Finally, the troponin was diluted to 1 M in stoppedflow buffer prior to use. The rate of Ca 2ϩ release was measured from the fluorescence enhancement of IAANS fluorescence upon emptying Ca 2ϩ from the regulatory site (40) by rapid mixing with an excess of EGTA. This was achieved by mixing 90 l of 1 M troponin with 10 l of 100 mM EGTA/KOH (pH 7.0) at 25°C using an Applied Photophysics SX-18MV stopped-flow spectrofluorometer equipped with a 400-nm filter (excitation at 325 nm). Rate constants were calculated by least squares fitting of the data to a single exponential function.
RESULTS

Phosphorylation Effects on Wild Type
Troponin- Fig. 2 shows a typical actomyosin ATPase activity versus pCa experiment. The mean (Ϯ S.E.) rates of ATP hydrolysis in our experiments were 2.5 Ϯ 0.1 and 12.5 Ϯ 0.4 nmol of P i released s Ϫ1 nmol Ϫ1 myosin at high and low pCa, respectively. The curves represent least-squares fits to the Hill equation, from which we obtain the pCa giving half maximal activity (pCa 50 ). The mean pCa 50 values from at least four repeats of the experiment were 6.35 for unphosphorylated troponin and 6.12 for bisphosphorylated troponin, i.e. phosphorylation reduces the pCa 50 by 0.23 pCa units (⌬pCa 50 ). This ⌬pCa 50 value is within the range reported in the literature (17) (18) (19) . The minimum and maximum ATPase activities and the cooperativity of regulation were not significantly altered by phosphorylation or by any of the mutations tested in this study. Control experiments (data not shown) using [␥-33 P]ATP to phosphorylate the thin filaments followed by SDS-PAGE and autoradiography demonstrated that the TnI was maximally phosphorylated (no increase in phosphorylation with longer incubation times) and that no other thin filament proteins were phosphorylated.
The stopped-flow measurement of Ca 2ϩ release from unphosphorylated and phosphorylated troponin containing wild type TnI and TnT and C84S TnC-IAANS is shown in Fig. 3 . In both cases the data is well fitted by a single exponential function. Ca 2ϩ release is measured from the 2-to 3-fold increase in the fluorescence of the IAANS attached to inactive site I of TnC produced by emptying of site II. The mean rate constants obtained were 25.5 s Ϫ1 for unphosphorylated troponin and 33.0 s Ϫ1 for phosphorylated troponin. This ϳ30% increase in the dissociation rate constant caused by TnI phosphorylation is somewhat less than the value of 45% reported in 1982 by Robertson et al. (19) using bovine cardiac troponin but is large enough to easily and reliably measure.
Phosphorylation Effects on Troponin Containing Pro 3 Ala TnI Mutants-We produced single (P15A), double (P15A/ P17A) and quadruple (P11A/P13A/P15A/P17A) Pro 3 Ala mutants of TnI. The rationale being that, if this region was acting as a rigid spacer arm, then replacement of the Pro residues with Ala would increase its flexibility and impair transmission of the phosphorylation signal. When treated with PKA, all three mutants incorporated phosphate to the same extent as wild type TnI (data not shown). The results of the ATPase and stopped-flow experiments are summarized in Tables I (a and b). All three mutants behave very much like wild type TnI with respect to the effects of phosphorylation: treatment with PKA produces a substantial shift to the right in the ATPase versus pCa plot and an increase in the Ca 2ϩ dissociation rate constant. These results indicate that none of the four Pro residues is important per se and that the stiffness of the postulated spacer arm region is not required to transmit the phosphorylation signal to TnC.
Phosphorylation Effects on Troponin Containing N-terminal Deletion Mutants of TnI-We constructed a series of TnI mutants with an increasing number of residues missing from the N terminus (Ϫ3, Ϫ6, Ϫ9, Ϫ13, Ϫ15, Ϫ16, Ϫ17, Ϫ18, Ϫ21, and Ϫ29). The deletions up to Ϫ18 were designed to test the role of the region of TnI N-terminal to the phosphorylation motif. All of the mutants up to and including Ϫ18 were phosphorylated by PKA at the same rate and to the same extent as wild type TnI (Fig. 4) . The Ϫ21 mutant is not phosphorylated by PKA, because the Arg-Arg-Xaa-Ser/Thr recognition motif for PKA has been disrupted (see Fig. 1 ), and in the Ϫ29 mutant the phosphorylation sites are deleted. The Ϫ21 and Ϫ29 mutants were designed to: 1) act as a control so that all the observed effects were actually due to phosphorylation of serines 22 and 23 and 2) test the effect of removing the whole of the Nterminal extension.
The pCa 50 values obtained in the ATPase experiments with the N-terminal deletion mutants of TnI are listed in Table II and plotted against the number of residues deleted in Fig. 5 . The ⌬pCa 50 upon phosphorylation is substantial (Ͼ0.12 pCa units) for all the deletion mutants up to and including Ϫ15. This shows that residues 1-15 play only a minor role if, any, in the transmission of the phosphorylation signal. Deletions Cterminal to Pro 15 reduce the ability of phosphorylation to produce a desensitization to Ca 2ϩ indicating an importance for residues 16 -18 . As one would predict, PKA treatment has no effect on the Ϫ21 and Ϫ29 mutants. However, as we remove residues C-terminal to Pro 15 we see a desensitization to Ca 2ϩ in the unphosphorylated state that mimics the effect of phosphorylation. Thus, it would appear that residues 16 -29 of TnI are responsible for holding cardiac troponin in the high Ca 2ϩ affinity unphosphorylated conformation. Stopped-flow measurement of Ca 2ϩ release was used to confirm the effects of phosphorylation on the deletion mutants. The dissociation rate constants are presented in Table III and are plotted against the number of residues deleted in Fig. 6 . The trends in the data mirror those seen in the ATPase experiments. Up to 15 residues can be removed from the N terminus of TnI without inhibiting the ability of phosphorylation to accelerate Ca 2ϩ release. We find that larger deletions (Ϫ18) halve the effect of phosphorylation on the Ca 2ϩ off rate. The effect of deleting the N-terminal extension is to accelerate Ca 2ϩ release mimicking the effects of phosphorylation as seen in the ATPase experiments. In fact, deleting the N-terminal extension is rather more effective at destabilizing Ca 2ϩ binding than phosphorylation. These results show that it is the unphosphorylated form of the N-terminal extension that actively stabilizes Ca 2ϩ binding and not the phosphorylated form that destabilizes Ca 2ϩ binding.
The Effect of Using Skeletal Isoforms of TnC and TnT- Table  IV shows the pCa 50 values obtained in ATPase experiments where the troponin was reconstituted using skeletal TnC or TnT rather than all three cardiac subunits. Replacing the cardiac TnT with skeletal TnT did not alter the ability of phosphorylation to produce a desensitization toward Ca 2ϩ . Skeletal TnT was also able to support the phosphorylation-induced acceleration of Ca 2ϩ release (data not shown). These results indicate that the sequence differences of cardiac TnT with respect to skeletal TnT are not adaptations relating to the phosphorylation effect. However, when the cardiac TnC was replaced with the skeletal isoform, phosphorylation of the TnI was unable to alter Ca 2ϩ sensitivity. This may be due to a specific effect, e.g. skeletal TnC not presenting a binding site for the N-terminal extension, or simply because the very different energetics of the skeletal TnC N-terminal domain (involving the binding of two Ca 2ϩ ions rather than one) override the effects of phosphorylation.
DISCUSSION
In our experiments we see clear effects of bisphosphorylation of cardiac TnI by PKA as previously reported (17) (18) (19) . Bisphosphorylation increases the Ca 2ϩ dissociation rate from troponin by ϳ30% and desensitizes actomyosin ATPase activity toward Ca 2ϩ by ϳ0.2 pCa units. We have used these effects to monitor the ability of mutations in the N-terminal extension of TnI to disrupt the transmission of the phosphorylation signal to the regulatory Ca 2ϩ site in the N-terminal domain of TnC.
The sequence of the N-terminal extension suggested to us that the conformational changes produced in the vicinity of the phosphoserine residues conformation (21, 22) might be transmitted via a rigid spacer arm to a TnC binding site in the first nine residues of TnI. We find, however, that this is not the case. The four Pro residues in the putative rigid spacer arm can be mutated to Ala without disrupting the effects of phosphorylation. Equally, residues 1-15 of TnI can be removed with little reduction in the effects of phosphorylation, leading us to conclude that the extreme N-terminal region of TnI (residues 1-15) is not required to transmit the phosphorylation signal to TnC. Amino acids equivalent to human cardiac TnI residues 1-9 are present in all mammalian cardiac TnIs sequenced to date but are less conserved between species than the rest of TnI ( Fig. 1) and may play a role other than other than transmitting the phosphorylation signal.
In 1991 Ikebe and Morita (41) found that removal of residues Arg 13 -Pro-Gln-Arg 16 of smooth muscle regulatory light chain abolished the effects of myosin light chain kinase-mediated phosphorylation of serine 19 (without preventing phosphoryl- ation). In TnI, however, removal of residues N-terminal to the phosphorylation sites only reduces but does not abolish the effect of phosphorylation: the effects of phosphorylation are severely reduced in the Ϫ16, Ϫ17, and Ϫ18 mutants. This suggests that Ala 16 , Pro 17 , and Ile 18 may be involved in the transmission mechanism, although we note that mutation of Pro 17 to Ala seems to be without effect. The phosphorylation of serines 22 and 23 introduces four negative charges into a positively charged region of the N-terminal extension. We therefore expected altered ionic interactions to underlie the effects of phosphorylation and were rather surprised that these relatively small hydrophobic residues attached to the Nterminal side of the bisphosphorylation motif were of much importance. They may, however, contribute directly to TnC binding or play a structural role in either the unphosphorylated or bisphosphorylated conformation of the N-terminal extension of TnI.
An important observation in this study is that progressively deleting residues 16 -29 very effectively mimics phosphorylation. This demonstrates that it is the unphosphorylated form of the N-terminal extension that is "active" in stabilizing Ca 2ϩ binding at the regulatory site. This conclusion is the opposite of that reached by Wattanapermpool et al. (42) in a comparison of wild type rat cardiac TnI with mouse cardiac TnI with residues 1-32 deleted. In skinned fiber experiments the Ϫ32 and fulllength TnI gave the same ATPase and force versus pCa relationships. Their conclusion was that the phosphorylated extension is the active form that destabilizes the Ca 2ϩ -bound form of TnC. However, several lines of evidence argue against the bisphosphorylated species being the active form, including two studies on skinned fibers and one with reconstituted regulated actomyosin ATPase assays in which the Ϫ32 mutation shifts pCa relationships to the right by 0.1-0.3 pCa units, mimicking phosphorylation (43) (44) (45) . Second, binding studies show that peptides corresponding to the N-terminal extension bind to TnC with an affinity of ϳ10 5 M Ϫ1 in the unphosphorylated state and that phosphorylation weakens this binding 100-fold (26, 27) . Two of these studies identify the TnC binding site on the N-terminal extension as between residues 16 and 29 (21) and 18 and 31 (26) . These are exactly the residues that, when removed, mimic phosphorylation. Indeed, the fact that the affinity of whole TnI for TnC is reduced upon phosphorylation may result directly from the loss of the N-terminal extension's binding contribution (46) . A third line of evidence is that of elegant NMR studies carried out by Rosevear and coworkers (28 -30) . These experiments show that a fragment of cardiac TnI (TnI-(1-80) ), containing the major TnC C-terminal domain binding site (within residues 33-80) and the N-terminal extension, makes contacts with the N-terminal domain of TnC (primarily in the inactive Ca 2ϩ binding site I). These contacts are not seen if serines 22 and 23 are mutated to Asp, if the TnI-(1-80) is bisphosphorylated, or if the TnI-(1-80) is replaced with TnI-(30 -80), i.e. if the N-terminal extension is deleted. They also showed that, in intact troponin, phosphorylation of TnI influenced the exchange between the open and closed conformations of the N-terminal domain of TnC and that, again, deletion of residues 1-30 mimicked phosphorylation.
We propose that when TnI is unphosphorylated residues 16 -28 of TnI bind to the N-terminal domain of TnC stabilizing the "open" Ca 2ϩ -bound conformation. Upon phosphorylation of serines 22 and 23, the introduction of negative charges and localized conformational changes within the N-terminal extension of TnI reduces its affinity for TnC relieving the stabilization of the open conformation and enhancing Ca 2ϩ release. Residues 1-15 are not crucial in this mechanism, but removal of the predicted TnC binding region (residues 16 -29) has exactly the same effect as phosphorylation.
Further work is required to exactly define the interactions between residues 16 -29 of TnI and TnC. Replacement of serines 22 and 23 with Ala has no effect on Ca 2ϩ sensitivity (17) indicating that the Ser side chains are not forming functionally important hydrogen bonds in unphosphorylated troponin. Our work suggests that residues in both regions 16 -21 and 24 -29 contribute to binding to TnC.
